{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:05:08Z","timestamp":1794895508108,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.antiviral.2020.104787","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:58:06Z","timestamp":1585879086000},"page":"104787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1596,"special_numbering":"C","title":["The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro"],"prefix":"10.1016","volume":"178","author":[{"given":"Leon","family":"Caly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian D.","family":"Druce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-1260","authenticated-orcid":false,"given":"Mike G.","family":"Catton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Jans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie M.","family":"Wagstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.antiviral.2020.104787_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1473-3099(19)30289-0","article-title":"Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial","volume":"19","author":"Buonfrate","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104787_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.antiviral.2012.06.008","article-title":"Nuclear trafficking of proteins from RNA viruses: potential target for anti-virals?","volume":"95","author":"Caly","year":"2012","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104787_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104787_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.antiviral.2020.104787_bib5","doi-asserted-by":"crossref","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"issue":"18","key":"10.1016\/j.antiviral.2020.104787_bib6","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum\/Golgi membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104787_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans--a mini-review","volume":"10","author":"Gonzalez Canga","year":"2008","journal-title":"AAPS J."},{"issue":"15","key":"10.1016\/j.antiviral.2020.104787_bib8","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104787_bib9","doi-asserted-by":"crossref","first-page":"23138","DOI":"10.1038\/srep23138","article-title":"Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import","volume":"6","author":"Gotz","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104787_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JVI.75.1.506-512.2001","article-title":"The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus","volume":"75","author":"Hiscox","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104787_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ceb.2019.01.001","article-title":"Inhibitors of nuclear transport","volume":"58","author":"Jans","year":"2019","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104787_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2019.03.012","article-title":"Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system","volume":"95","author":"Ketkar","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"12","key":"10.1016\/j.antiviral.2020.104787_bib13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1515\/hsz-2015-0171","article-title":"The importin alpha\/beta-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways","volume":"396","author":"Kosyna","year":"2015","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104787_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104787_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.antiviral.2013.10.004","article-title":"Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication","volume":"100","author":"Lundberg","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104787_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.antiviral.2018.09.010","article-title":"Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo","volume":"159","author":"Lv","year":"2018","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104787_bib17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104787_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkz524","article-title":"Safety of high-dose ivermectin: a systematic review and meta-analysis","volume":"75","author":"Navarro","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104787_bib19","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2214-109X(19)30453-X","article-title":"Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis","volume":"8","author":"Nicolas","year":"2020","journal-title":"Lancet Global Health"},{"issue":"9","key":"10.1016\/j.antiviral.2020.104787_bib20","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1128\/JVI.75.9.4399-4401.2001","article-title":"Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor","volume":"75","author":"Ono","year":"2001","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.antiviral.2020.104787_bib21","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1128\/JVI.79.17.11507-11512.2005","article-title":"Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells","volume":"79","author":"Rowland","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104787_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","article-title":"Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin","volume":"99","author":"Tay","year":"2013","journal-title":"Antivir. Res."},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2020.104787_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virusres.2005.05.007","article-title":"Nuclear\/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus","volume":"114","author":"Timani","year":"2005","journal-title":"Virus Res."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104787_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1535-7163.MCT-15-0052","article-title":"Targeting the nuclear import receptor Kpnbeta1 as an anticancer therapeutic","volume":"15","author":"van der Watt","year":"2016","journal-title":"Mol. Canc. Therapeut."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104787_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1087057110390360","article-title":"An AlphaScreen(R)-based assay for high-throughput screening for specific inhibitors of nuclear import","volume":"16","author":"Wagstaff","year":"2011","journal-title":"J. Biomol. Screen"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104787_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin alpha\/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104787_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2020.104787_bib28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fmicb.2015.00553","article-title":"Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses","volume":"6","author":"Wulan","year":"2015","journal-title":"Front. Microbiol."},{"issue":"19","key":"10.1016\/j.antiviral.2020.104787_bib29","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1128\/JVI.75.19.9345-9356.2001","article-title":"Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division","volume":"75","author":"Wurm","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104787_bib30","series-title":"He 34th Annual Meeting the Royal College of Physicians of Thailand","article-title":"Efficacy and safety of ivermectin against dengue infection: a phase III, randomized, double-blind, placebo-controlled trial","author":"Yamasmith","year":"2018"},{"key":"10.1016\/j.antiviral.2020.104787_bib31","doi-asserted-by":"crossref","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha\/beta1 heterodimer","author":"Yang","year":"2020","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:04Z","timestamp":1759062784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":31,"alternative-id":["S0166354220302011"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104787","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104787"}}